2023 Symposium on the Longevity Factor HDL

Program

Opening
10:00 ~ 10:10		 Opening Ceremony and Congratulatory Address
Session 1
10:10 ~ 10:40
HDL and Cardiometabolic Health
Anand Rohatgi, M.D.ㅣ Professor of Medicine, University of Texas Southwestern Medical Center, Division of Cardiology (US)
HDL and Cardiometabolic Health
Anand Rohatgi, M.D.ㅣ Professor of Medicine, University of Texas Southwestern Medical Center, Division of Cardiology (US)
Session 2
10:40 ~ 11:10
Clinical Translation of Synthetic High-Density Lipoprotein Therapeutics and Drug Carriers
Anna Schwendeman, Ph.D.ㅣ Professor of Pharmaceutical Sciences, University of Michigan (US)
Clinical Translation of Synthetic High-Density Lipoprotein Therapeutics and Drug Carriers
Anna Schwendeman, Ph.D.ㅣ Professor of Pharmaceutical Sciences, University of Michigan (US)
Session 3
11:15 ~ 11:40
The cross-talk between HDL and SARS-CoV-2 infection
Theodoros Kelesidis, M.D., Ph.D., M.Sc.ㅣ Associate Professor, University of Texas Southwestern Medical Center, Division of Infectious Diseases, UT Southwestern Medical Center (US)
The cross-talk between HDL and SARS-CoV-2 infection
Theodoros Kelesidis, M.D., Ph.D., M.Sc.ㅣ Associate Professor, University of Texas Southwestern Medical Center, Division of Infectious Diseases, UT Southwestern Medical Center (US)
Lunch 11:40 ~ 13:00
Session 4
13:00 ~ 13:30
HDL and Cerebral Cholesterol Metabolism : Novel Target in Neurodegenerative Disorders
Francesca Zimetti, Ph.D. ㅣ Associate Professor of Pharmacology, Department of Food and Drugs, University of Parma (ITA)
HDL and Cerebral Cholesterol Metabolism : Novel Target in Neurodegenerative Disorders
Francesca Zimetti, Ph.D. ㅣ Associate Professor of Pharmacology, Department of Food and Drugs, University of Parma (ITA)
Session 5
13:30 ~ 14:00
The Cuban policosanol
Sarahi Mendoza Castano, Ph.D. ㅣ Director of Research, Development and Innovation, National Center for Scientific Research (CUB)
The Cuban policosanol
Sarahi Mendoza Castano, Ph.D. ㅣ Director of Research, Development and Innovation, National Center for Scientific Research (CUB)
Session 6
14:00 ~ 14:30
Policosanol In Post ischemic stroke therapy
Javier Vicente Sanchez Lopez, Ph.D. ㅣ President of the national commission on cerebrovascular diseases, National Institute of Neurology and Neurosciences (CUB)
Policosanol In Post ischemic stroke therapy
Javier Vicente Sanchez Lopez, Ph.D. ㅣ President of the national commission on cerebrovascular diseases, National Institute of Neurology and Neurosciences (CUB)
Break Time 14:30 ~ 14:50
Session 7
14:50 ~ 15:35
Roles of HDL for Atherosclerosis, and Beneficial Effects of Cuban Policosanol for HDL Function from Randomized Clinical Trial in Japan
Yoshinari UEHARA, M.D., Ph.D. ㅣ Professor, Department of Cardiology, Fukuoka Univ. Hospital (JPN)
Roles of HDL for Atherosclerosis, and Beneficial Effects of Cuban Policosanol for HDL Function from Randomized Clinical Trial in Japan
Yoshinari UEHARA, M.D., Ph.D. ㅣ Professor, Department of Cardiology, Fukuoka Univ. Hospital (JPN)
Session 8
15:20 ~ 15:50
Enhancement of HDL in quantity and quality by Cuban policosanol (Raydel®) with improvement of blood pressure and protection activity in the liver, ovary, and testis: comparison with Chinese and American policosanols
Kyung Hyun Cho, Ph.D ㅣ Head of RAYDEL Research Institute (KOR)
Enhancement of HDL in quantity and quality by Cuban policosanol (Raydel®) with improvement of blood pressure and protection activity in the liver, ovary, and testis: comparison with Chinese and American policosanols
Kyung Hyun Cho, Ph.D ㅣ Head of RAYDEL Research Institute (KOR)

Panel

  • Alberto Formis, M.D.
    Director of the Rehabilitation Unit, San Clemente Private Hospital (ITA)
  • Steven Schwendeman, Ph.D.
    Professor of Pharmaceutical Sciences, University of Michigan (US)
  • Gillian Martinez Donato, Ph.D.
    Business Development Project Manager, CIGB (Center of Genetic Engineering and Biotechnology) (CUB)
  • Talena Yasmile Ledon Perez, Ph.D.
    Deputy Director, CNIC (National Centre for Scientific Research) (CUB)